Lista de obras -

AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance

artículo científico publicado en 2014

An Active Efflux System for Heavy Metals in Cisplatin-Resistant Human KB Carcinoma Cells ⬇️

artículo científico publicado el 1 de mayo de 1998

BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance

artículo científico publicado en 2020

CDX2 Stimulates the Proliferation of Porcine Intestinal Epithelial Cells by Activating the mTORC1 and Wnt/β-Catenin Signaling Pathways.

artículo científico publicado en 2017

Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer

scientific article published on 02 September 2020

Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp)

artículo científico publicado en 2020

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells ⬇️

artículo científico

Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates ⬇️

artículo científico publicado en 2019

Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy

scientific article published on 01 May 2019

Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-Glycoprotein

artículo científico publicado en 2017

Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10−/− Mice ⬇️

artículo científico publicado el 15 de mayo de 2011

Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review

artículo científico publicado en 2022

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters

artículo científico publicado en 2018

Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acid

artículo científico publicado en 2014

Dual TTK/CLK2 inhibitor, CC-671, selectively antagonizes ABCG2-mediated multidrug resistance in lung cancer cells

artículo científico publicado en 2020

Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells

artículo científico publicado en 2017

Enhanced sorption of radiocobalt from water by Bi(III) modified montmorillonite: A novel adsorbent ⬇️

artículo científico publicado el 10 de mayo de 2011

Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications

artículo científico publicado en 2020

Establishment and characterization of arsenic trioxide resistant KB/ATO cells

artículo científico publicado en 2017

Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer

artículo científico publicado en 2016

Exploring naturally occurring ivy nanoparticles as an alternative biomaterial

artículo científico publicado en 2015

GSK1904529A, a Potent IGF-IR Inhibitor, Reverses MRP1-Mediated Multidrug Resistance.

artículo científico publicado en 2017

Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells

artículo científico publicado en 2015

High quality 2D crystals made by anodic bonding: a general technique for layered materials ⬇️

artículo científico publicado el 29 de noviembre de 2012

IKK inhibition increases bortezomib effectiveness in ovarian cancer

artículo científico publicado en 2015

Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2.

artículo científico publicado en 2014

Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing

artículo científico publicado en 2020

Identification of new potent anticancer derivatives through simplifying the core structure and modification on their 14- hydroxyl group from oridonin

artículo científico publicado en 2022

In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1.

artículo científico publicado en 2014

Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078 ⬇️

artículo científico publicado el 14 de agosto de 1998

Lipid-Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo

artículo científico publicado en 2020

Long non-coding RNAs regulate drug resistance in cancer

scientific article published on 12 March 2020

Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor

artículo científico publicado en 2020

Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.

artículo científico publicado en 2014

Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases ⬇️

artículo científico publicado el 1 de agosto de 2011

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

artículo científico publicado en 2022

Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates

artículo científico publicado en 2014

Oncosis-inducing cyclometalated iridium(iii) complexes

artículo científico publicado en 2018

Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells

artículo científico publicado en 2021

Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells

artículo científico publicado en 2020

PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia

artículo científico publicado en 2016

PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN

artículo científico publicado en 2022

Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy

artículo científico publicado en 2015

Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs

artículo científico publicado en 2013

Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance

artículo científico publicado en 2014

Reversal of Heavy Metal Resistance in Multidrug-Resistant Human KB Carcinoma Cells ⬇️

artículo científico publicado el 30 de julio de 1997

Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P ⬇️

artículo científico publicado el 3 de julio de 1998

Selective reversal of BCRP-mediated MDR by VEGFR-2 inhibitor ZM323881.

artículo científico publicado en 2017

Special Issue: Natural Products: Anticancer and Beyond.

artículo científico publicado en 2018

Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators

artículo científico publicado en 2020

Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport

artículo científico publicado en 2017

Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin

artículo científico publicado en 2015

Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression

scientific article published on 30 November 2019

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer

scientific article published on 17 January 2020

The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein Transporter ⬇️

artículo científico publicado el 28 de abril de 2011

The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms ⬇️

artículo científico publicado el 19 de diciembre de 2012

The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade

artículo científico

Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance

scientific article published on 12 January 2020

Triterpenoids as reversal agents for anticancer drug resistance treatment ⬇️

artículo científico publicado el 13 de agosto de 2013

Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance ⬇️

artículo científico publicado el 9 de febrero de 2012

miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer

artículo científico publicado en 2014

Lista de obras de

AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance

An Active Efflux System for Heavy Metals in Cisplatin-Resistant Human KB Carcinoma Cells ⬇️

BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance

CDX2 Stimulates the Proliferation of Porcine Intestinal Epithelial Cells by Activating the mTORC1 and Wnt/β-Catenin Signaling Pathways.

Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer

Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp)

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells ⬇️

Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates ⬇️

Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy

Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-Glycoprotein

Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10−/− Mice ⬇️

Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters

Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acid

Dual TTK/CLK2 inhibitor, CC-671, selectively antagonizes ABCG2-mediated multidrug resistance in lung cancer cells

Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells

Enhanced sorption of radiocobalt from water by Bi(III) modified montmorillonite: A novel adsorbent ⬇️

Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications

Establishment and characterization of arsenic trioxide resistant KB/ATO cells

Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer

Exploring naturally occurring ivy nanoparticles as an alternative biomaterial

GSK1904529A, a Potent IGF-IR Inhibitor, Reverses MRP1-Mediated Multidrug Resistance.

Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells

High quality 2D crystals made by anodic bonding: a general technique for layered materials ⬇️

IKK inhibition increases bortezomib effectiveness in ovarian cancer

Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2.

Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing

Identification of new potent anticancer derivatives through simplifying the core structure and modification on their 14- hydroxyl group from oridonin

In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1.

Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078 ⬇️

Lipid-Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo

Long non-coding RNAs regulate drug resistance in cancer

Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor

Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.

Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases ⬇️

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates

Oncosis-inducing cyclometalated iridium(iii) complexes

Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells

Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells

PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia

PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN

Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy

Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs

Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance

Reversal of Heavy Metal Resistance in Multidrug-Resistant Human KB Carcinoma Cells ⬇️

Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P ⬇️

Selective reversal of BCRP-mediated MDR by VEGFR-2 inhibitor ZM323881.

Special Issue: Natural Products: Anticancer and Beyond.

Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators

Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport

Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin

Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer

The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein Transporter ⬇️

The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms ⬇️

The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade

Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance

Triterpenoids as reversal agents for anticancer drug resistance treatment ⬇️

Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance ⬇️

miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer